Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

Insmed's TPIP Shows Promising Results in Phase 2 PAH Trial, Advancing to Phase 3

Insmed's TPIP Shows Promising Results in Phase 2 PAH Trial, Advancing to Phase 3

Insmed, a biopharmaceutical company specializing in rare diseases, has reported exceptional results from its phase 2b trial of treprostinil palmitil inhalation powder (TPIP) for the treatment of pulmonary arterial hypertension (PAH). The study outcomes have surpassed expectations, potentially marking a significant advancement in prostanoid therapy for PAH patients.

NoahAI News6/11/2025
Medtronic Appoints Kate Benedict as New Head of Acute Care and Monitoring

Medtronic Appoints Kate Benedict as New Head of Acute Care and Monitoring

Medtronic, a leading medical technology company, has announced the appointment of Kate Benedict as the new president of its Acute Care and Monitoring (ACM) business. Benedict, a seasoned healthcare executive with over 25 years of experience, will also serve on the leadership team for Medtronic's medical surgical portfolio.

NoahAI News6/11/2025
Scorpion Therapeutics Spins Out Antares with $177M Series A, Sells Clinical Assets to Pierre Fabre

Scorpion Therapeutics Spins Out Antares with $177M Series A, Sells Clinical Assets to Pierre Fabre

Scorpion Therapeutics, a Boston-based biotech company, has announced a significant restructuring of its operations, including the spinout of a new company and the sale of its clinical assets. This move comes on the heels of Eli Lilly's acquisition of Scorpion's PI3Kα program earlier this year.

NoahAI News6/11/2025
Elekta Appoints New CEO to Drive Growth and Profitability in Radiotherapy Market

Elekta Appoints New CEO to Drive Growth and Profitability in Radiotherapy Market

Elekta, a leading player in the cancer radiotherapy market, has announced the appointment of Jakob Just-Bomholt as its new president and CEO, effective September 1, 2025. This strategic move comes as the Stockholm-based company seeks to improve profitability and drive global expansion in the competitive radiotherapy sector.

NoahAI News6/11/2025
Prime Healthcare Cuts 100 Roles at Illinois Hospitals Amid Acquisition Integration

Prime Healthcare Cuts 100 Roles at Illinois Hospitals Amid Acquisition Integration

Prime Healthcare, a major player in the U.S. healthcare landscape, has announced significant staff reductions at its recently acquired Illinois hospitals. This move comes as part of the company's efforts to streamline operations following its largest-ever acquisition earlier this year.

NoahAI News6/11/2025
Capital Rx Acquires Amino Health, Signaling Shift in Benefit Platform Landscape

Capital Rx Acquires Amino Health, Signaling Shift in Benefit Platform Landscape

In a significant move that underscores the evolving dynamics of the healthcare benefits sector, alternative pharmacy benefit manager Capital Rx has announced its acquisition of care navigation company Amino Health. This strategic merger aims to create a seamless, unified medical and pharmacy claims platform, potentially reshaping the industry landscape.

NoahAI News6/11/2025
Novo Nordisk Expands Obesity Pipeline with $812M Deep Apple Deal

Novo Nordisk Expands Obesity Pipeline with $812M Deep Apple Deal

Novo Nordisk, a leader in the obesity treatment market, has inked a significant deal with Deep Apple Therapeutics, further solidifying its position in the rapidly evolving field of weight management therapies. The agreement, valued at up to $812 million, focuses on developing small molecules targeting a non-incretin G protein-coupled receptor (GPCR) for the treatment of obesity and related cardiometabolic diseases.

NoahAI News6/11/2025
AMA Leadership Changes Amid Calls for Healthcare Reform and Research Funding

AMA Leadership Changes Amid Calls for Healthcare Reform and Research Funding

The American Medical Association (AMA) has undergone its annual leadership transition, ushering in a new era of advocacy for the nation's largest physician association. This change comes at a critical time for the healthcare industry, as it grapples with challenges ranging from chronic disease prevention to technological modernization.

NoahAI News6/11/2025
ASH Launches $12M Initiative to Support Hematology Research Amid Federal Funding Cuts

ASH Launches $12M Initiative to Support Hematology Research Amid Federal Funding Cuts

The American Society of Hematology (ASH) has announced a significant $12 million funding initiative to support hematology research in response to recent federal budget cuts. This move comes as part of a broader effort by scientific organizations to mitigate the impact of reduced government funding on vital medical research.

NoahAI News6/11/2025
Somnee Secures $10M in Funding, Advancing AI-Powered Sleep Technology

Somnee Secures $10M in Funding, Advancing AI-Powered Sleep Technology

Somnee, a neuroscience-based sleep technology company, has raised $10 million in a seed extension round led by Khosla Ventures. The funding will support the launch of the company's second-generation sleep tech wearable device, which utilizes artificial intelligence to improve sleep quality.

NoahAI News6/11/2025
Oxford and Recipharm Expand Malaria Vaccine Partnership, Advancing Clinical Trials

Oxford and Recipharm Expand Malaria Vaccine Partnership, Advancing Clinical Trials

The University of Oxford and Swedish contract development and manufacturing organization (CDMO) Recipharm have announced an expansion of their long-standing collaboration in malaria vaccine development. This partnership, which began in 2016, has now been broadened to encompass additional manufacturing responsibilities for two promising blood-stage malaria vaccine candidates currently undergoing phase 1/2 clinical trials.

NoahAI News6/11/2025
Recursion Pharmaceuticals Cuts Workforce by 20% to Extend Cash Runway

Recursion Pharmaceuticals Cuts Workforce by 20% to Extend Cash Runway

Recursion Pharmaceuticals, a Utah-based biotech company, announced a significant reduction in its workforce as part of a strategic initiative to streamline operations and extend its financial runway. The company, which specializes in AI-driven drug discovery, disclosed the layoffs in an SEC filing on Tuesday, revealing plans to cut approximately 20% of its staff, affecting around 160 employees.

NoahAI News6/10/2025
«1...495051...67»